A FAST, COMPREHENSIVE APPROACH FOR RE-OPENING YOUR CV SERVICE LINE

Partner News | Published: Monday, May 4, 2020 8:00 am


As we emerge from the unprecedented COVID-19 crisis, programs across the country are seeking a safe, rational approach to re-opening their Cath Labs and resuming elective revascularization. MedAxiom Industry Partner, Health Outcomes Sciences (HOS), has developed a toolkit that identifies patients who most need angiography and revascularization, determines the best treatment plan to rapidly and safely discharge them, while quantifying the benefits of treatment for patients, payers, and administrators. As areas in the country move to re-opening, this tool will be invaluable to our members. 

The HOS COVID-19 RESTART PROTOCOL & TOOLKIT:

  • Can be quickly incorporated into existing ePRISM workflows and allows programs to get back to work
  • Incorporates Federal and state guidelines for elective procedures
  • Encompasses published guidance from SCAI, ACC, and the CDC
  • Includes a HOS-created solution to facilitate quick and accurate decisions
  • Available NOW within the HOS ePrism platform or as a stand-alone decision tool

 

CLICK HERE FOR A FREE 3-MONTH TRIAL

 

The HOS Covid-19 Restart Protocol & Toolkit starts with a survey to capture patient history, labs, vitals and demographics, along with the Seattle Angina Questionnaire (SAQ), a well-validated and widely used 19-item instrument that measures patient-reported symptoms, function and quality of life for patients with coronary artery disease. 

SDD Survey

 

SAQ SURVEY

 

The HOS Covid-19 Restart Protocol & Toolkit stratifies patients in low, moderate, or high risk and priority. 

 

The HOS Covid-19 Restart Protocol & Toolkit makes recommendations for same day discharge WHILE CONSIDERING RELATED AKI AND BLEEDING RISKS. 

 

CLICK HERE FOR A FREE 3-MONTH TRIAL